Add to Favorites

China Breast Cancer Diagnosis Market 2013-2023: Unmet Needs & Opportunities




Report Overview

There are about 1.38 million new cases and 458,000 deaths due to breast cancer each year (IARC Globocan, 2008). Breast cancer is by far the most common type of cancer among the female population worldwide, both in the developed and developing countries. In low- and middle-income countries the incidence has been on the rise steadily in recent years, due to increase in life expectancy, increasing urbanization and adoption of western lifestyles.


Compared with its western counterparts, China has a relatively lower incidence of breast cancer, but has been rising by 3%-4% every year. With the pursuit of early detection and improved prognosis among Chinese women, the market of breast cancer diagnosis presents great potential in future.


Through Loudon’s research effort, this report will put you in the right path of strategic thinking and serve to provide some answers to the frequently asked questions: What is the current market landscape of breast cancer diagnosis, where seems to be the opportunities and challenges amongst the various categories of diagnostic technology, including imaging test, tumor markers, immunohistochemical test and histopathologic examinations.


Key Report Features


  • Summary of Key Findings

  • Screening of Breast Cancer
          - Definition of High Risk Group
          - Screening Method of Breast Cancer in different countries
          - Evaluation on Breast Cancer Screening

  • Flow Chart for Breast Cancer Patients
          - Screening and confirmation Places
          - Diagnosis of patients screened in PEC (physical examination centers)
          - Diagnosis of patients screened in hospital departments

  • Value Chain Analysis Breast Cancer Diagnosis

  • Staging of Breast Cancer

  • Evaluation on Diagnosis Tools and Unmet Needs Analysis
          - Evaluation on diagnosis tools
          - Hospital service prices breast cancer examination items

          - Unmet needs analysiss


  • Market Overview and Projection 2013-2023
          - Breast cancer incident population
          - Market imaging tests and tumor marker
          - Market immunohistochemical test, endoscopy & biopsy
          - Breast cancer diagnosis market by product segments
          - Breast cancer diagnosis market by rural and urban population

The report is in about 56 pages in English presentation format.


Who Would Benefit From This Report?

CEOs
Sales & Marketing VPs
R & D
BD/Marketing/ Medical Directors
Researchers
Financial Analysts in pharmaceutical, medical device
Private and institutional investors in life science industry
Payer organizations / Insurance companies
NGOs with focus on women’s rights and well being

Publication date

Aug 15, 2013.


Cost

5,000 RMB or 800 USD per subscription.



*You can send E-mailEmail to LFE to purchase this report.

 


Please transfer the RMB or USD payments to the following account:

 

A/C: Shanghai Loudon Marketing Consultant Co., Ltd
A/C: No. 444259223258
Bank Name: Bank of China Shanghai, FanYu Road Sub-branch
Swift code: BKCHCNBJ300

 

Name Beneficiary：Loudon Far East B.V. The Netherlands
Bank Name：ING Bank N.V.
Account No：67.38.48.906
IBAN：NL23INGB 0673848906
BIC/SWIFT：INGBNL2A

 

 

 



Ordering application form

Step 1:

Please choose the report you are interested in, click "More information" button.

Step 2:

Please go through the brief introduction of the report carefully and click "E-mail" link in the end of the page.

Step 3:

Please finish filling your required information in the e-mail.

Step 4:

After sending E-mail to Loudon, our client service person will contact you afterwards.


*If any questions, please contact our client service person.

Tel: +86-21-6290 2121-107

Email: jenny.zhu@loudon-research.com

(All free during 10:00~18:00 every work-day)